Thermo Fisher Scientific | TMO - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
Abbott USD 3.27B 138M 2026-03
Agilent USD 465M 11M 2026-03
Becton, Dickinson and Co. USD 1.21B 180M 2026-03
Bio Techne USD 109.34M 4.35M 2026-03
Bio-Rad Laboratories USD 221M 14.2M 2025-12
Boston Scientific USD 1.78B 53M 2026-03
Bruker USD 242.1M 5.1M 2026-03
Charles River Laboratories USD 159.42M 36.71M 2026-03
Danaher USD 1.86B 166M 2026-03
Dentsply International USD 351M 32M 2026-03
Edwards Lifesciences USD 522.2M 80.7M 2026-03
General Electric Aerospace USD 1.08B 496M 2026-03
Henry Schein USD 809M 1000K 2026-03
Illumina USD 272M 11M 2026-03
Intuitive Surgical USD 613.3M 73.8M 2026-03
IQVIA Holdings USD 502M 34M 2026-03
Laboratory Of America USD 551M 12.4M 2026-03
Medtronic 2.96B 9M 2025-12
Mettler Toledo International USD 258.33M 1.5M 2026-03
Myriad Genetics USD 122.3M 6.7M 2025-12
Olympus JPY 139.34B 13.69B 2026-03
OraSure Technologies USD 13.21M 3.29M 2025-12
Quest Diagnostics USD 504M 0 2026-03
Repligen USD 76.54M 2.17M 2026-03
Revvity USD 253.88M 2.15M 2026-03
Stryker USD 2.15B 17M 2026-03
Thermo Fisher Scientific USD 1.8B 179M 2026-03
Veracyte USD 50.84M 7.53M 2026-03
Waters USD 394M 153.99M 2026-03
Zimmer Biomet Holdings USD 849.9M 5.8M 2026-03